American Journal of Respiratory and Critical Care Medicine

The following articles, featured in the April issue of the Journal (volume 155, no. 4), had their references incorrectly numbered. They should have appeared as follows:

“Sialomucin Expression is Associated with erbB-2 Oncoprotein Overexpression, Early Recurrence, and Cancer Death in Non-Small-Cell Lung Cancer” by Yu, et al., pp. 1419–1427.

1. Parkin D. M., Pisani P., Ferlay J.Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer541993594606
2. Valaitis J., Warren S., Gamble D.Increasing incidence of adenocarcinoma of the lung. Cancer41198110421046
3. Minna, J. D., H. Pass, E. Glastein, and D. C. Ihde. 1989. Carcinoma of the lung. In V. T. Devita, Jr., S. Hellman, and S. A. Rosenberg, editors. Cancer: Principles and Practice of Oncology. J. B. Lippincott, Philadelphia. 591–703.
4. Sagawa M., Saito Y., Takahashi S., Usuda K., Kamma K., Sato M., Ota S.-I., Nagamoto N., Fujimura S., Nakada T., Hashimoto K., Suda H., Imai T., Saito H.Clinical and prognostic assessment of patients with resected small peripheral lung cancer lesions. Cancer66199026532657
5. Devereux T. R., Taylor J. A., Barrett J. C.Molecular mechanisms of lung cancer: interaction of environmental and genetic factors. Chest109(Suppl.)199614S19S
6. World Health OrganizationThe World Health Organization histological typing of lung tumors. Am. J. Clin. Pathol19821982123136
7. Itzkowitz S. H., Bloom E. J., Kokal W. A., Modin G., Hakomori S., Kim Y. S.Sialyl-Tn—a novel mucin antigen associated with prognosis in colorectal carcinoma patients. Cancer66199019601966
8. McGuckin M. A., Walsh M. D., Hohn B. G., Ward B. G., Wright R. G.Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum. Pathol261995432439
9. Devine P. L., McKenzie I. F. C.Mucins: structure, function and associations with malignancy. Bioessays141992619625
10. Kawai T., Suzuki M., Kase K., Ozeki Y.Expression of carbohydrate antigens in human pulmonary adenocarcinoma. Cancer72199315811587
11. Orawa J.-I., Sano A., Koide S., Shohtsu A.Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl Lewisx, and sialyl Lewisa in lung cancer. J. Thorac. Cardiovasc. Surg1081994329336
12. Mountain, C. F. 1986. A new international staging system for lung cancer. Chest 89(Suppl. 4):225–233.
13. Harpole D. H., Herndon J. E., Wolfe W. G., Iglehart J. D., Marks J. R.A prognostic model of recurrence and death in stage I non-small-cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res5519955156
14. Xerri L., Payan M.-J., Choux R., Gros N., Figarella-Branger D., Sarles H.Predominance of sialomucin secretion in malignant and premalignant pancreatic lesions. Hum. Pathol211990927931
15. Glantz, S. A. 1987. Primer of Biostatics, 2nd ed. McGraw-Hill, New York. 101–137.
16. Kaplan E. L., Meier P.Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc531958457481
17. Cox D. R.Regression Models and life tables. J. R. Stat. Soc. (Series B)341972187200
18. Linnoila R. I., Piantadosi S., Ruckdeschel J. C.Impact of neuroendocrine differentiation in non-small-cell lung carcinoma: the LCSG experience. Chest106(Suppl.)1994367S371S
19. Graziano S. L., Tatum A. H., Newman N. B., Oler A., Kohman L. J., Veit L. J., Gamble G. P., Coleman M. J., Barmada S., O'Lear S.The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small-cell lung cancer. Cancer Res54199429082913
20. Clayton F.Bronchioloalveolar carcinomas: cell types, patterns of growth, and prognostic correlates. Cancer57198615551564
21. Correa P.A human model of gastric carcinogenesis. Cancer Res48198835543560
22. Allen D. C., Connolly N. S., Biggart J. D.High iron diamine–alcian blue mucin profiles in benign, premalignant and malignant colorectal disease. Histopathology131988399411
23. Otaga S., Maimonis P. J., Itzkowitz S. H.Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity. Cancer Res52199247414746
24. Gendler S. J., Spicer A. P.Epithelial mucin genes. Annu. Rev. Physiol571995607634
25. Hilkens J., Lightenberg M. J. L., Vos H. L., Litvinov S. V.Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem. Sci171992359363
26. Charest M. P., Roth J.Localization of sialic acid in kidney glomeruli: regionalization in the podocyte plasma membrane and loss in experimental nephrosis. Proc. Natl. Acad. Sci. U.S.A82198585088512
27. Ho J. J. L., Chang S., Kim Y. S.Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids. Biochem. Biophys. Res. Commun2101995866873
28. Yogeeswaran G.Cell membrane glycolipids and glycoproteins in malignant transformation. Adv. Cancer Res381982289350
29. Petrick A. T., Meterissian S., Steele G., Thomas P.Desialylation of human colorectal carcinoma cells facilitates binding to Kupffer cells. Clin. Exp. Metastasis121994108116
30. Kakari S., Stringou E., Toumbis M., Ferderigos A. S., Poulaki E., Chondros K., Dema A., Kotsovoulou V., Pavlidis N.Five tumor markers in lung cancer: significance of total and “lipid”-bound sialic acid. Anticancer Res11199121072110
31. Thomas P.Cell surface sialic acid as a mediator of metastatic potential in colorectal cancer. Cancer J919963236
32. Kern J. A., Schwartz D. A., Nordberg J. E., Weiner D. B., Greene M., Torney L., Robinson R. A.p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res50199051845191
33. Wu K., Fregein N., Carraway K. L.Molecular cloning and sequencing of the mucin subunit of a heterodimeric, bifunctional cell surface glycoprotein complex of ascites rat mammary adenocarcinoma cells. J. Biol. Chem26919941195011955
34. Satoh K., Sasano H., Shimosegawa T., Koizumi M., Yamazaki T., Mochizuki F., Kobayashi N., Okano T., Toyota T., Sawai T.An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas. Cancer7219935156
35. Carbone D. P., Mitsudomi T., Chiba I., Piantadosi S., Rusch V., Nowak J. A., McIntyre D., Slamon D., Gazdar A., Minna J.P53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer: a preliminary report of LCSG 871. Chest106(Suppl.)1994377S381S
American Journal of Respiratory and Critical Care Medicine

Click to see any corrections or updates and to confirm this is the authentic version of record